319 related articles for article (PubMed ID: 31858537)
1. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
[TBL] [Abstract][Full Text] [Related]
2. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
[TBL] [Abstract][Full Text] [Related]
3. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
4.
Liu Q; Lei C
Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
[TBL] [Abstract][Full Text] [Related]
10. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
[TBL] [Abstract][Full Text] [Related]
12. Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.
Xu H; Wang L; Jiang X
Mol Cell Biochem; 2021 Feb; 476(2):1051-1061. PubMed ID: 33170430
[TBL] [Abstract][Full Text] [Related]
13. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2.
Li P; Wu Q; Yang XR; Sun T
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5988-5995. PubMed ID: 32572912
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
Zhang YJ; Lu C
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
Zhang W; Liu S; Liu K; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5154-5164. PubMed ID: 31207081
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
20. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]